共 45 条
- [34] Efficacy and safety of switching from basal insulin to once-daily insulin degludec/insulin aspart in Japanese patients with inadequately controlled type 2 diabetes: A 4-week, randomized, open-label, treat-to-target study JOURNAL OF DIABETES INVESTIGATION, 2018, 9 (03): : 567 - 572
- [35] Effects of physician's diabetes self-management education using Japan Association of Diabetes Education and Care Diabetes Education Card System Program and a self-monitoring of blood glucose readings analyzer in individuals with type 2 diabetes: An exploratory, open-labeled, prospective randomized clinical trial JOURNAL OF DIABETES INVESTIGATION, 2021, 12 (12) : 2221 - 2231
- [36] Metabolic effects of two years of exenatide treatment on diabetes, obesity, and hepatic biomarkers in patients with type 2 diabetes: An interim analysis of data from the open-label, uncontrolled extension of three double-blind, placebo-controlled trials CLINICAL THERAPEUTICS, 2007, 29 (01) : 139 - 153
- [38] Patient Demographics and Clinical Outcomes Among Type 1 Diabetes Patients Using Continuous Glucose Monitors: Data From T1D Exchange Real-World Observational Study JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY, 2023, 17 (02): : 322 - 328
- [39] Randomized clinical trial of the efficacy and safety of insulin glargine vs. NPH insulin as basal insulin for the treatment of glucocorticoid induced hyperglycemia using continuous glucose monitoring in hospitalized patients with type 2 diabetes and respiratory disease DIABETES RESEARCH AND CLINICAL PRACTICE, 2015, 110 (02) : 158 - 165
- [40] A randomized, open-label, multicentre, parallel-controlled study comparing the efficacy and safety of biphasic insulin aspart 30 plus metformin with biphasic insulin aspart 30 monotherapy for type 2 diabetes patients inadequately controlled with oral antidiabetic drugs: The merit study DIABETES OBESITY & METABOLISM, 2018, 20 (12) : 2740 - 2747